Breaking News Instant updates and real-time market news.

STLJF

Stella-Jones

$0.00 /

+ (+0.00%)

11:04
08/06/20
08/06
11:04
08/06/20
11:04

Stella-Jones price target raised to C$46 from C$42 at Scotiabank

Scotiabank analyst Mark Neville raised the firm's price target on Stella-Jones to C$46 from C$42 and keeps a Sector Perform rating on the shares.

STLJF Stella-Jones
$0.00 /

+ (+0.00%)

08/06/20 TD Securities
Stella-Jones price target raised to C$52 from C$47 at TD Securities
07/24/20 CIBC
Stella-Jones price target raised to C$45 from C$42 at CIBC
07/21/20 TD Securities
Stella-Jones price target raised to C$47 from C$41 at TD Securities
07/06/20 CIBC
Stella-Jones price target raised to C$42 from C$41 at CIBC

TODAY'S FREE FLY STORIES

Earnings
Accenture sees FY21 GAAP EPS $7.80-$8.10, consensus $8.13 » 06:46
09/24/20
09/24
06:46
09/24/20
06:46
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

Sees FY21 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Upgrade
Square upgraded to Outperform upon re-assumption of coverage at Oppenheimer » 06:46
09/24/20
09/24
06:46
09/24/20
06:46
SQ

Square

$149.56 /

-6.085 (-3.91%)

Oppenheimer analyst Jed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

06:40 Today Oppenheimer
Square upgraded to Outperform from Perform at Oppenheimer
06:23 Today Mizuho
Square's Cash App is 'virtually unstoppable,' says Mizuho
09/22/20
Top five analyst initiations
09/22/20 Loop Capital
Square initiated with a Buy at Loop Capital
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

Hot Stocks
Accenture raises quarterly dividend 10%, approves $5B share repurchase  06:45
09/24/20
09/24
06:45
09/24/20
06:45
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

 
ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Earnings
Accenture reports Q4 EPS $1.70, consensus $1.73 » 06:44
09/24/20
09/24
06:44
09/24/20
06:44
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Recommendations
Cintas good news increasingly priced in to shares, says Baird » 06:43
09/24/20
09/24
06:43
09/24/20
06:43
CTAS

Cintas

$316.86 /

-7.64 (-2.35%)

Baird analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTAS Cintas
$316.86 /

-7.64 (-2.35%)

CTAS Cintas
$316.86 /

-7.64 (-2.35%)

06:34 Today RBC Capital
Cintas price target raised to $360 from $347 at RBC Capital
09/18/20 Baird
Cintas designated a Fresh Pick into earnings,at Baird
07/24/20 RBC Capital
Cintas price target raised to $347 from $318 at RBC Capital
07/21/20 Jefferies
Cintas price target raised to $325 from $302 at Jefferies
CTAS Cintas
$316.86 /

-7.64 (-2.35%)

CTAS Cintas
$316.86 /

-7.64 (-2.35%)

CTAS Cintas
$316.86 /

-7.64 (-2.35%)

Initiation
Bionano Genomics initiated with a Buy at Ladenburg » 06:42
09/24/20
09/24
06:42
09/24/20
06:42
BNGO

Bionano Genomics

$0.59 /

-0.0342 (-5.48%)

Ladenburg initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNGO Bionano Genomics
$0.59 /

-0.0342 (-5.48%)

BNGO Bionano Genomics
$0.59 /

-0.0342 (-5.48%)

04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
04/08/20 Oppenheimer
Bionano Genomics initiated with an Outperform at Oppenheimer
BNGO Bionano Genomics
$0.59 /

-0.0342 (-5.48%)

Syndicate
Square files to sell 14M shares of common stock » 06:42
09/24/20
09/24
06:42
09/24/20
06:42
SQ

Square

$149.56 /

-6.085 (-3.91%)

Goldman, BofA Securities,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

06:40 Today Oppenheimer
Square upgraded to Outperform from Perform at Oppenheimer
06:23 Today Mizuho
Square's Cash App is 'virtually unstoppable,' says Mizuho
09/22/20
Top five analyst initiations
09/22/20 Loop Capital
Square initiated with a Buy at Loop Capital
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

Hot Stocks
MediciNova's ibudilast shows neurotoxicity improvement or stabilization in study » 06:40
09/24/20
09/24
06:40
09/24/20
06:40
MNOV

MediciNova

$6.00 /

+0.45 (+8.11%)

MediciNova announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNOV MediciNova
$6.00 /

+0.45 (+8.11%)

MNOV MediciNova
$6.00 /

+0.45 (+8.11%)

MNOV MediciNova
$6.00 /

+0.45 (+8.11%)

Upgrade
Square upgraded to Outperform from Perform at Oppenheimer » 06:40
09/24/20
09/24
06:40
09/24/20
06:40
SQ

Square

$149.56 /

-6.085 (-3.91%)

Oppenheimer analyst Jed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

06:23 Today Mizuho
Square's Cash App is 'virtually unstoppable,' says Mizuho
09/22/20
Top five analyst initiations
09/22/20 Loop Capital
Square initiated with a Buy at Loop Capital
09/16/20 Mizuho
Square lending product could add 10% in gross profit, says Mizuho
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

Upgrade
Centrica upgraded to Overweight from Neutral at JPMorgan » 06:40
09/24/20
09/24
06:40
09/24/20
06:40
CPYYY

Centrica

/

+

JPMorgan analyst Javier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPYYY Centrica
/

+

CPYYY Centrica
/

+

08/04/20 HSBC
Centrica upgraded to Hold from Reduce at HSBC
08/04/20 HSBC
Centrica upgraded to Hold from Reduce at HSBC
07/29/20 UBS
Centrica price target raised to 50 GBp from 30 GBp at UBS
07/28/20 Jefferies
Centrica upgraded to Buy from Hold at Jefferies
Recommendations
H.B. Fuller forward outlook healthy for shares, says Baird » 06:40
09/24/20
09/24
06:40
09/24/20
06:40
FUL

H.B. Fuller

$46.23 /

-1.41 (-2.96%)

Baird analyst Ghansham…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUL H.B. Fuller
$46.23 /

-1.41 (-2.96%)

FUL H.B. Fuller
$46.23 /

-1.41 (-2.96%)

06/29/20 Citi
H.B. Fuller price target raised to $46 from $30 at Citi
06/26/20 Deutsche Bank
H.B. Fuller price target raised to $45 from $31 at Deutsche Bank
04/17/20 JPMorgan
H.B. Fuller upgraded to Overweight on longer-term potential at JPMorgan
04/17/20 JPMorgan
H.B. Fuller upgraded to Overweight from Neutral at JPMorgan
FUL H.B. Fuller
$46.23 /

-1.41 (-2.96%)

FUL H.B. Fuller
$46.23 /

-1.41 (-2.96%)

FUL H.B. Fuller
$46.23 /

-1.41 (-2.96%)

Upgrade
Evraz upgraded to Equal Weight from Underweight at Morgan Stanley » 06:37
09/24/20
09/24
06:37
09/24/20
06:37
EVRZF

Evraz

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVRZF Evraz
$0.00 /

+ (+0.00%)

08/20/20 JPMorgan
Evraz price target raised to 500 GBp from 330 GBp at JPMorgan
07/22/20 JPMorgan
Evraz price target raised to 330 GBp from 300 GBp at JPMorgan
06/23/20 Morgan Stanley
Evraz price target raised to 270 GBp from 250 GBp at Morgan Stanley
06/17/20 Goldman Sachs
Evraz resumed with a Sell at Goldman Sachs
Hot Stocks
Aerie Pharma's Roclanda meets non-inferiority objective in Phase 3 trial » 06:35
09/24/20
09/24
06:35
09/24/20
06:35
AERI

Aerie Pharmaceuticals

$11.66 /

-0.45 (-3.72%)

Aerie Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$11.66 /

-0.45 (-3.72%)

AERI Aerie Pharmaceuticals
$11.66 /

-0.45 (-3.72%)

09/08/20
Fly Intel: Top five analyst initiations
09/08/20 Guggenheim
Aerie Pharmaceuticals initiated with a Buy at Guggenheim
08/07/20 Mizuho
Aerie Pharmaceuticals price target lowered to $27 from $29 at Mizuho
08/07/20 Piper Sandler
Aerie Pharmaceuticals price target lowered to $25 from $35 at Piper Sandler
AERI Aerie Pharmaceuticals
$11.66 /

-0.45 (-3.72%)

AERI Aerie Pharmaceuticals
$11.66 /

-0.45 (-3.72%)

Recommendations
Marathon Petroleum price target lowered to $30 from $38 at Citi » 06:34
09/24/20
09/24
06:34
09/24/20
06:34
MPC

Marathon Petroleum

$28.71 /

-2.32 (-7.48%)

, MPLX

MPLX

$15.91 /

-0.945 (-5.61%)

Citi analyst Prashant Rao…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPC Marathon Petroleum
$28.71 /

-2.32 (-7.48%)

MPLX MPLX
$15.91 /

-0.945 (-5.61%)

MPC Marathon Petroleum
$28.71 /

-2.32 (-7.48%)

09/11/20 JPMorgan
Marathon Petroleum price target lowered to $37 from $44 at JPMorgan
08/12/20 Cowen
Marathon Petroleum upgraded to Outperform from Market Perform at Cowen
08/04/20 Tudor Pickering
Marathon Petroleum downgraded to Sell from Buy at Tudor Pickering
08/03/20 Morgan Stanley
Marathon sale of Speedway for $21B a 'positive outcome,' says Morgan Stanley
MPLX MPLX
$15.91 /

-0.945 (-5.61%)

09/09/20 Goldman Sachs
MPLX initiated with a Buy at Goldman Sachs
08/03/20 Morgan Stanley
Marathon sale of Speedway for $21B a 'positive outcome,' says Morgan Stanley
07/15/20 Morgan Stanley
MPLX downgraded to Equal Weight from Overweight at Morgan Stanley
07/15/20 Morgan Stanley
MPLX downgraded to Equal Weight from Overweight at Morgan Stanley
MPC Marathon Petroleum
$28.71 /

-2.32 (-7.48%)

MPLX MPLX
$15.91 /

-0.945 (-5.61%)

MPC Marathon Petroleum
$28.71 /

-2.32 (-7.48%)

MPLX MPLX
$15.91 /

-0.945 (-5.61%)

MPC Marathon Petroleum
$28.71 /

-2.32 (-7.48%)

MPLX MPLX
$15.91 /

-0.945 (-5.61%)

MPC Marathon Petroleum
$28.71 /

-2.32 (-7.48%)

MPLX MPLX
$15.91 /

-0.945 (-5.61%)

Recommendations
Cintas price target raised to $360 from $347 at RBC Capital » 06:34
09/24/20
09/24
06:34
09/24/20
06:34
CTAS

Cintas

$316.86 /

-7.64 (-2.35%)

RBC Capital analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTAS Cintas
$316.86 /

-7.64 (-2.35%)

CTAS Cintas
$316.86 /

-7.64 (-2.35%)

09/18/20 Baird
Cintas designated a Fresh Pick into earnings,at Baird
07/24/20 RBC Capital
Cintas price target raised to $347 from $318 at RBC Capital
07/21/20 Jefferies
Cintas price target raised to $325 from $302 at Jefferies
06/11/20 RBC Capital
Cintas price target raised to $318 from $250 at RBC Capital
CTAS Cintas
$316.86 /

-7.64 (-2.35%)

CTAS Cintas
$316.86 /

-7.64 (-2.35%)

CTAS Cintas
$316.86 /

-7.64 (-2.35%)

Hot Stocks
Co-Diagnostics announces Logix Smart ABCTest to launch in October » 06:32
09/24/20
09/24
06:32
09/24/20
06:32
CODX

Co-Diagnostics

$13.45 /

-1.645 (-10.90%)

Co-Diagnostics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CODX Co-Diagnostics
$13.45 /

-1.645 (-10.90%)

CODX Co-Diagnostics
$13.45 /

-1.645 (-10.90%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
CODX Co-Diagnostics
$13.45 /

-1.645 (-10.90%)

CODX Co-Diagnostics
$13.45 /

-1.645 (-10.90%)

CODX Co-Diagnostics
$13.45 /

-1.645 (-10.90%)

CODX Co-Diagnostics
$13.45 /

-1.645 (-10.90%)

Upgrade
Silicon Motion upgraded to Outperform from Neutral at Wedbush » 06:32
09/24/20
09/24
06:32
09/24/20
06:32
SIMO

Silicon Motion

$37.24 /

-0.76 (-2.00%)

Wedbush analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIMO Silicon Motion
$37.24 /

-0.76 (-2.00%)

08/21/20 B. Riley FBR
Silicon Motion valuation 'unusually compelling,' says B. Riley FBR
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/22/20 Cowen
Silicon Motion price target raised to $60 from $54 at Cowen
04/30/20 Craig-Hallum
Silicon Motion price target raised to $55 from $50 at Craig-Hallum
SIMO Silicon Motion
$37.24 /

-0.76 (-2.00%)

SIMO Silicon Motion
$37.24 /

-0.76 (-2.00%)

Recommendations
General Mills price target lowered to $64 from $70 at Citi » 06:30
09/24/20
09/24
06:30
09/24/20
06:30
GIS

General Mills

$57.74 /

-0.26 (-0.45%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIS General Mills
$57.74 /

-0.26 (-0.45%)

GIS General Mills
$57.74 /

-0.26 (-0.45%)

08/28/20
Fly Intel: Top five analyst initiations
08/28/20 Citi
General Mills initiated with a Neutral at Citi
08/28/20 Citi
Kellogg initiated with a Buy at Citi
07/15/20 Guggenheim
General Mills price target raised to $72 from $66 at Guggenheim
GIS General Mills
$57.74 /

-0.26 (-0.45%)

GIS General Mills
$57.74 /

-0.26 (-0.45%)

GIS General Mills
$57.74 /

-0.26 (-0.45%)

GIS General Mills
$57.74 /

-0.26 (-0.45%)

Recommendations
Masonite price target raised to $116 from $111 at RBC Capital » 06:28
09/24/20
09/24
06:28
09/24/20
06:28
DOOR

Masonite

$90.08 /

+0.04 (+0.04%)

RBC Capital analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOOR Masonite
$90.08 /

+0.04 (+0.04%)

DOOR Masonite
$90.08 /

+0.04 (+0.04%)

09/16/20 Wedbush
Masonite price target raised to $103 from $97 at Wedbush
07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Northcoast
Northcoast cuts Masonite to Neutral with expectations high, stock doubled
07/20/20 Northcoast
Masonite downgraded to Neutral from Buy at Northcoast
DOOR Masonite
$90.08 /

+0.04 (+0.04%)

Upgrade
Seaport upgrades Andersons to Buy on improving grain sector fundamentals » 06:28
09/24/20
09/24
06:28
09/24/20
06:28
ANDE

Andersons

$17.95 /

-0.69 (-3.70%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANDE Andersons
$17.95 /

-0.69 (-3.70%)

ANDE Andersons
$17.95 /

-0.69 (-3.70%)

06:19 Today Seaport Global
Andersons upgraded to Buy from Neutral at Seaport Global
09/14/20 BMO Capital
Andersons upgraded to Outperform from Market Perform at BMO Capital
08/26/20 National Securities
Andersons initiated with a Buy at National Securities
07/28/20 Seaport Global
Andersons initiated with a Neutral at Seaport Global
ANDE Andersons
$17.95 /

-0.69 (-3.70%)

ANDE Andersons
$17.95 /

-0.69 (-3.70%)

Recommendations
Regenxbio price target lowered to $79 from $88 at Barclays » 06:27
09/24/20
09/24
06:27
09/24/20
06:27
RGNX

Regenxbio

$28.59 /

-0.28 (-0.97%)

, NVS

Novartis

$87.45 /

-1.42 (-1.60%)

Barclays analyst Gena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RGNX Regenxbio
$28.59 /

-0.28 (-0.97%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

RGNX Regenxbio
$28.59 /

-0.28 (-0.97%)

09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/25/20 BofA
Regenxbio reinstated with a Buy at BofA
05/12/20 RBC Capital
Regenxbio initiated with a Sector Perform at RBC Capital
NVS Novartis
$87.45 /

-1.42 (-1.60%)

09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/23/20 Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
RGNX Regenxbio
$28.59 /

-0.28 (-0.97%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

RGNX Regenxbio
$28.59 /

-0.28 (-0.97%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

Recommendations
Square's Cash App is 'virtually unstoppable,' says Mizuho » 06:23
09/24/20
09/24
06:23
09/24/20
06:23
SQ

Square

$149.56 /

-6.085 (-3.91%)

After meeting with Square…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

09/22/20
Top five analyst initiations
09/22/20 Loop Capital
Square initiated with a Buy at Loop Capital
09/16/20 Mizuho
Square lending product could add 10% in gross profit, says Mizuho
08/27/20 Mizuho
Mizuho starts Square with Buy rating, $225 price target
SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

SQ Square
$149.56 /

-6.085 (-3.91%)

Upgrade
ZoomInfo upgraded to Buy from Hold at Canaccord » 06:22
09/24/20
09/24
06:22
09/24/20
06:22
ZI

ZoomInfo

$35.44 /

+1.02 (+2.96%)

Canaccord analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZI ZoomInfo
$35.44 /

+1.02 (+2.96%)

ZI ZoomInfo
$35.44 /

+1.02 (+2.96%)

09/23/20 Wells Fargo
ZoomInfo upgraded at Wells Fargo as favorable entry point takes shape
09/23/20 Wells Fargo
ZoomInfo upgraded to Overweight from Equal Weight at Wells Fargo
09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 JPMorgan
ZoomInfo upgraded to Overweight after 36% pullback at JPMorgan
ZI ZoomInfo
$35.44 /

+1.02 (+2.96%)

  • 20
    Aug
  • 04
    Jun
ZI ZoomInfo
$35.44 /

+1.02 (+2.96%)

Initiation
DraftKings initiated with an Outperform at Macquarie » 06:21
09/24/20
09/24
06:21
09/24/20
06:21
DKNG

DraftKings

$50.08 /

-3.87 (-7.17%)

Macquarie analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKNG DraftKings
$50.08 /

-3.87 (-7.17%)

DKNG DraftKings
$50.08 /

-3.87 (-7.17%)

06:17 Today Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
06:04 Today Macquarie
DraftKings initiated with an Outperform at Macquarie
09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/15/20 Craig-Hallum
DraftKings price target raised to $60 from $48 at Craig-Hallum
DKNG DraftKings
$50.08 /

-3.87 (-7.17%)

  • 19
    Jun
DKNG DraftKings
$50.08 /

-3.87 (-7.17%)

DKNG DraftKings
$50.08 /

-3.87 (-7.17%)

DKNG DraftKings
$50.08 /

-3.87 (-7.17%)

Upgrade
Andersons upgraded to Buy from Neutral at Seaport Global » 06:19
09/24/20
09/24
06:19
09/24/20
06:19
ANDE

Andersons

$17.95 /

-0.69 (-3.70%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANDE Andersons
$17.95 /

-0.69 (-3.70%)

ANDE Andersons
$17.95 /

-0.69 (-3.70%)

09/14/20 BMO Capital
Andersons upgraded to Outperform from Market Perform at BMO Capital
08/26/20 National Securities
Andersons initiated with a Buy at National Securities
07/28/20 Seaport Global
Andersons initiated with a Neutral at Seaport Global
10/07/19
Andersons initiated with an Equal Weight at Stephens
ANDE Andersons
$17.95 /

-0.69 (-3.70%)

ANDE Andersons
$17.95 /

-0.69 (-3.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.